Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

Recommendations

Info

242 Applying Pharmacogenomics in Therapeutics143. Ma L, Roman-Campos D, Austin ED, et al. A novel channelopathy in pulmonary arterialhypertension. The New England Journal of Medicine 2013;369:351–61.144. Patel AJ, Honore E, Lesage F, Fink M, Romey G, Lazdunski M. Inhalational anestheticsactivate two-pore-domain background K+ channels. Nature Neuroscience 1999;2:422–6.145. Hartness ME, Lewis A, Searle GJ, O’Kelly I, Peers C, Kemp PJ. Combined antisenseand pharmacological approaches implicate hTASK as an airway O(2) sensing K(+)channel. The Journal of Biological Chemistry 2001;276:26499–508.146. Olschewski A, Li Y, Tang B, et al. Impact of TASK-1 in human pulmonary arterysmooth muscle cells. Circulation Research 2006;98:1072–80.147. Smith BP, Best DH, Elliott CG. Genetics and pharmacogenomics in pulmonary arterialhypertension. Heart Failure Clinics 2012;8:319–30.148. Eadon MT, Wheeler HE, Stark AL, et al. Genetic and epigenetic variants contributingto clofarabine cytotoxicity. Human Molecular Genetics 2013;22:4007–20.
10Pharmacogenomics andAlternative MedicineMerge of Future and TraditionWei Zhang, Xiao-Ping Chen, and Hong-Hao ZhouCONTENTSKey Concepts..........................................................................................................244Introduction.............................................................................................................244Vitamins..................................................................................................................245Case Report........................................................................................................245Vitamin B 12 .........................................................................................................247Vitamin C...........................................................................................................248Vitamin D...........................................................................................................249Vitamin E...........................................................................................................249Vitamin K...........................................................................................................250Folic Acid...........................................................................................................250Minerals and Trace Elements.................................................................................. 251Case Report........................................................................................................ 252Selenium............................................................................................................. 252Calcium.............................................................................................................. 253Iron..................................................................................................................... 255Magnesium......................................................................................................... 255Potassium...........................................................................................................256Chromium.......................................................................................................... 257Herbal Medicines.................................................................................................... 257Case Report........................................................................................................262St. John’s Wort...................................................................................................262Ginkgo................................................................................................................263Baicalin..............................................................................................................263Garlic..................................................................................................................263Grapefruit Juice..................................................................................................263Cranberry Juice..................................................................................................263Tianqi Jiangtang.................................................................................................264Artichoke............................................................................................................264Pomegranate Juice..............................................................................................265243
Page 1:
ApplyingPharmacogenomicsin Therapeu
Page 5 and 6:
ApplyingPharmacogenomicsin Therapeu
Page 7:
DedicationWe dedicate this book to
Page 10 and 11:
viiiContentsChapter 10 Pharmacogeno
Page 13 and 14:
EditorsXiaodong Feng, PhD, PharmD,
Page 15 and 16:
ContributorsWeiguo Chen, PhDDepartm
Page 17 and 18:
1Concepts inPharmacogenomics andPer
Page 19 and 20:
Concepts in Pharmacogenomics and Pe
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
2Principles ofPharmacogeneticBiotec
Page 51 and 52:
Principles of Pharmacogenetic Biote
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65:
Page 68 and 69:
52 Applying Pharmacogenomics in The
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 91 and 92:
4 ApplyingPharmacogenomicsin Drug D
Page 93 and 94:
Applying Pharmacogenomics in Drug D
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
5 Pharmacogenomicsand Laboratory Me
Page 113 and 114:
Pharmacogenomics and Laboratory Med
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157:
Page 160 and 161:
144 Applying Pharmacogenomics in Th
Page 162 and 163:
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209: 192 Applying Pharmacogenomics in Th
Page 217 and 218: 8Clinical Applicationsof Pharmacoge
Page 219 and 220: Pharmacogenomics of CNS Disorder Tr
Page 237 and 238: 9 ApplyingPharmacogenomicsin the Th
Page 239 and 240: Applying Pharmacogenomics in the Th
Page 257: Applying Pharmacogenomics in the Th
Page 261 and 262: Pharmacogenomics and Alternative Me
Page 287 and 288: 11 PharmacoeconogenomicsA Good Marr
Page 289 and 290: Pharmacoeconomics of Pharmacogenomi
Page 303 and 304: 5’3’5’3’ 5’3’ 5’3’3
Page 305 and 306: 1 2 3 4 5Vysis LSI BCR/ABL + 9q34 t
Page 307: BIOMEDICAL SCIENCEApplying Pharmaco
show all

Feng, Xiaodong_ Xie, Hong-Guang - Applying pharmacogenomics in therapeutics-CRC Press (2016)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?